• Ventilator management starts with physiology: determine whether your problem is primarily oxygenation (O₂) or ventilation (CO₂).
• Respiratory drive is mostly CO₂-driven: central chemoreceptors contribute ~80% of drive by sensing CSF/extracellular H⁺ (an indirect read of CO₂), while peripheral chemoreceptors contribute ~20% by sensing low PaO₂, high PaCO₂, and low pH.
• Dead space is the portion of each breath that does not participate in gas exchange:
  • Anatomic dead space: conducting airways not involved in exchange (~2 mL/kg IBW).
  • Alveolar dead space: ventilated alveoli with inadequate perfusion.
  • Physiologic dead space: anatomic + alveolar dead space.
  • Mechanical dead space: breathing system volume containing exhaled gas (patient airway → Y-piece), ~75–150 mL.
• V/Q matching: normal ventilation is ~4 L/min and perfusion ~5 L/min, so normal V/Q ≈ 0.8. Matching is supported by gravity distribution, hypoxic pulmonary vasoconstriction, and autoregulation.
• Physiologic shunt: perfused lung without adequate ventilation → arterial hypoxia that is not improved with oxygen therapy. Common causes: atelectasis, pulmonary edema, pneumonia, mucus plugging, endobronchial intubation, ARDS, right-to-left intracardiac shunts.
• PaCO₂ vs EtCO₂: normally PaCO₂ > EtCO₂ with a gap of ~2–5 mmHg. A widened gap suggests increased dead space and/or impaired perfusion. EtCO₂ falling disproportionately suggests poor perfusion. If EtCO₂ > PaCO₂, think rebreathing CO₂.
• Breath-hold CO₂ rise (helpful for “apnea tolerance” thinking):
  • Awake: PaCO₂ rises ~7 mmHg/min for the first 10 seconds, ~2 mmHg/min in the next 10 seconds, then ~6 mmHg/min thereafter.
  • Anesthetized: PaCO₂ rises ~12 mmHg in the first minute, then ~3.5 mmHg/min after.

• Central chemoreceptors (≈80% of drive): sense CO₂ indirectly by sensing CSF/extracellular H⁺ at the medulla.
• Peripheral chemoreceptors (≈20% of drive): carotid and aortic bodies sense low PaO₂, high PaCO₂, and low pH.
• Mechanoreceptors/reflexes: pulmonary stretch receptors (Hering–Breuer reflex), irritant receptors, J-receptors.
• Cortical inputs: can override automaticity; influenced by hypothalamus/limbic system (emotion, pain, temperature).

• Key definition: dead space is the portion of tidal volume that does not participate in gas exchange.
• Anatomic dead space: conducting airways (≈2 mL/kg IBW).
• Alveolar dead space: ventilated but underperfused alveoli.
• Physiologic dead space: anatomic + alveolar dead space.
• Mechanical dead space: breathing system volume (patient airway → Y-piece), ~75–150 mL.

• Normal V/Q ≈ 0.8 (Ventilation ~4 L/min, Perfusion ~5 L/min).
• Shunt (O₂ problem): perfused lung with inadequate ventilation → hypoxia that does not improve with oxygen therapy.
• Dead space (CO₂ problem): ventilated lung with inadequate perfusion → widened PaCO₂–EtCO₂ gap and “CO₂ won’t clear like it should.”

Step 1 — Oxygenation (SpO₂/PaO₂)

• If hypoxia is present, consider whether the pattern fits shunt (atelectasis, edema, pneumonia, mucus plugging, endobronchial intubation, ARDS, intracardiac R→L shunt).
• Remember: physiologic shunt hypoxia is not improved with oxygen therapy alone—you often need recruitment/PEEP and to fix the cause.

Step 2 — Ventilation (EtCO₂/PaCO₂)

• Use PaCO₂ vs EtCO₂ to interpret CO₂ clearance:
  • Normal: PaCO₂ > EtCO₂, gap ~2–5 mmHg.
  • Widened gap: increased dead space and/or decreased perfusion.
  • EtCO₂ falling disproportionately: perfusion problem.
  • EtCO₂ > PaCO₂: CO₂ rebreathing.
• Dead space is “wasted ventilation”—increasing minute ventilation may not fully correct PaCO₂ if perfusion is the limiter.

Step 3 — Dead Space: Identify What Kind

• Anatomic (conducting airways) is fairly stable, but can be functionally increased with long circuits/tubes.
• Mechanical dead space can increase with added connectors/adapters (patient airway → Y-piece).
• Alveolar dead space increases when ventilation is present but perfusion drops (think hemodynamics and pulmonary vascular tone).

• Shunt pattern: low SpO₂, often limited improvement with higher FiO₂; think recruitment/PEEP and the underlying cause.
• Dead space pattern: rising PaCO₂ and/or widening PaCO₂–EtCO₂ gap; consider perfusion and causes of underperfused ventilation.
• Reality: patients often have a mix—use trends and responses to changes to separate which problem is dominant.

• Confirm your “O₂ vs CO₂” hypothesis with numbers:
  • SpO₂ trend and FiO₂ requirement.
  • EtCO₂ trend and capnogram quality.
  • PaCO₂ if ABG/VBG available and the PaCO₂–EtCO₂ gap (normal ~2–5 mmHg).
• Confirm dead space concerns: widening PaCO₂–EtCO₂ gap and/or EtCO₂ dropping out of proportion to ventilation changes suggests perfusion issues (alveolar dead space).
• Confirm shunt concerns: persistent hypoxia despite increased FiO₂ suggests shunt physiology; re-check for atelectasis, mucus plugging, pulmonary edema, endobronchial migration, ARDS patterns, or intracardiac shunt risk.
• Confirm rebreathing if EtCO₂ > PaCO₂: evaluate circuit/FGF/CO₂ absorber setup and any changes that might increase rebreathing.

• Baseline: initial ventilation approach and physiologic rationale (oxygenation vs ventilation priority).
• Key trends: SpO₂, EtCO₂, and any ABG/PaCO₂ values with noted PaCO₂–EtCO₂ gap when clinically relevant.
• Major intraoperative events that change physiology: positioning changes, insufflation/pneumoperitoneum start, major retractors, suspected endobronchial migration, mucus plugging, atelectasis concerns.
• Interventions tied to physiology: recruitment/PEEP changes for shunt patterns; perfusion/ventilation strategy adjustments for dead space patterns; steps taken if rebreathing suspected.

• CO₂ Ventilatory Response Curve: (insert your slide/figure here)
• Dead Space Diagram: anatomic vs alveolar vs physiologic vs mechanical (insert figure)
• Shunt vs Dead Space (O₂ vs CO₂) one-liner graphic: (insert figure)
• PaCO₂ vs EtCO₂ gap quick reference: normal 2–5 mmHg; widened gap = dead space/perfusion; EtCO₂ > PaCO₂ = rebreathing